semaglutide vs tirzepatide for diabetes versus Once Weekly in Patients with Type 2 is glp-1/gip the same as

Its given as a once-weekly subcutaneous injection and follows this standard titration: Weeks 1 through 4: 2.5 mg Weeks 5 through 8: 5 mg Weeks 9 through 12: 7.5 mg (if moving toward higher doses) Weeks 13 through 16: 10 mg Weeks 17 through 20: 12.5 mg Week 20 onward: 15 mg (maximum dose) Not everyone will go to 15 mg

Noticeable changes usually happen after 8 to 12 weeks, but some may see small results as early as four weeks

This comprehensive approach is particularly beneficial for patients who struggle with insulin resistance, a common issue in type 2 diabetes

However, the efficacy of the drug has yet to be confirmed by further studies

It is a dual incretin receptor agonist that fundamentally changes how your body processes food, regulates blood sugar, and even responds to reward signals in your brain